Mark Michael

(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a Novel Xanthine-Based Dipeptidyl Peptidase 4 Inhibitor, Has a Superior Potency and Longer Duration of Action Compared with Other Dipeptidyl Peptidase-4 Inhibitors

Leo Thomas, Matthias Eckhardt, Elke Langkopf et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 277 citations

Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury

Pinelopi P. Kapitsinou, Hideto Sano, Mark Michael et al. · Journal of Clinical Investigation · 2014 · 180 citations · Full text

Acute Lung Injury, Ischemia Reperfusion, Renal Pathology +26

The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice

Pinelopi P. Kapitsinou, Ganeshkumar Rajendran, Lindsay Astleford et al. · Molecular and Cellular Biology · 2016 · 132 citations · Full text

Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury

Pinelopi P. Kapitsinou, Jonathan T. Jaffe, Mark Michael et al. · American Journal of Physiology-Renal Physiology · 2012 · 115 citations · Full text

Inflammation, Preischemic Targeting, Fibrosis +15

The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Attenuates Inflammation and Accelerates Epithelialization in Wounds of Diabetic ob/ob Mice

Christoph Schürmann, Andreas Linke, Kerstin Engelmann-Pilger et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 87 citations